Starling Oncology, Inc. (DFPH)

Import this data to Google Sheets with:

=jivedata("DFPH","financials")

Full statements spill as a table. For one cell: =jivedata("DFPH","Revenue") or =jivedata("DFPH","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Starling Oncology, Inc.

DFPH • CIK 0001799191

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Operating Income (Loss)	$-77,018	$-60,118	$-36,083	$-26,090
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-83,104	$-64,663	$-60,737	$-36,293
Income Tax Expense (Benefit)	$-36	$0	$-131	$0
Net Income (Loss) Attributable to Parent	$-83,068	$-64,663	$-60,606	$-36,293
Revenue from Contract with Customer, Excluding Assessed Tax	$324,239	$393,412	$502,729	$587,244
Selling, General and Administrative Expense	$113,851	$107,828	$105,574	$111,446
Depreciation, Depletion and Amortization, Nonproduction	$5,873	$6,287	$6,944	$6,809
Operating Costs and Expenses	$401,257	$453,530	$538,812	$613,334
InterestExpenseNonoperating	—	$7,496	$11,276	$7,629
Fair Value Adjustment of Warrants	$286	$-619	$247	$-23
Derivative, Gain (Loss) on Derivative, Net	$878	$2,697	$-12,206	$-3,157
Other Nonoperating Income (Expense)	$-704	$-365	$-925	$560
Nonoperating Income (Expense)	$-6,086	$-4,545	$-24,654	$-10,203
Net Income (Loss) Available to Common Stockholders, Basic	$-67,877	$-53,005	$-50,305	$-30,563
Weighted Average Number of Shares Outstanding, Basic	73,748,660	75,043,678	92,389,381	109,613,596

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$33,488	$49,669	$33,565	$41,094
Accounts Receivable, after Allowance for Credit Loss, Current	$42,360	$48,335	$58,998	$66,349
Property, Plant and Equipment, Net	$10,883	$11,888	$10,684	$10,583
Other Receivables, Net, Current	$551	$346	$322	$360
Operating Lease, Right-of-Use Asset	$29,169	$25,782	$22,374	$21,188
Inventory, Net	$13,678	$10,039	$16,875	$20,011
Intangible Assets, Net (Excluding Goodwill)	$17,904	$14,810	$11,015	$9,585
Prepaid Expense and Other Assets, Current	$4,049	$4,029	$2,987	$1,176
Goodwill	$7,230	$7,230	$7,230	$7,230
Assets, Current	$143,493	$112,418	$112,747	$128,990
Other Assets, Noncurrent	$561	$589	$606	$657
Assets	$209,240	$172,717	$164,656	$178,233
Operating Lease, Liability, Noncurrent	$26,486	$23,223	$19,131	$17,384
Derivative Liability, Noncurrent	$3,082	$385	$12,591	$10,838
Long-term Debt, Excluding Current Maturities	$86,826	$93,131	$77,400	$79,867
Other Liabilities, Noncurrent	$365	$125	$28	$30
Deferred Income Tax Liabilities, Net	$32	$32	$0	$0
Liabilities	$152,215	$169,128	$180,376	$203,147
Commitments and Contingencies	$0	$0	$0	$0
Accounts Payable, Current	$14,429	$24,324	$43,167	$60,279
Operating Lease, Liability, Current	$6,363	$6,798	$7,156	$7,225
Accrued Liabilities, Current	$13,996	$21,093	$20,639	$27,435
Liabilities, Current	$34,788	$52,215	$70,962	$94,939
Common Stock, Value, Issued	$8	$8	$10	$10
Additional Paid in Capital	$204,186	$215,413	$256,708	$259,795
Treasury Stock, Common, Value	$1,019	$1,019	$1,019	$1,019
Retained Earnings (Accumulated Deficit)	$-146,150	$-210,813	$-271,419	$-283,700
Stockholders' Equity Attributable to Parent	$57,025	$3,589	$-15,720	$-24,914
Common Stock, Shares Authorized	500,000,000	500,000,000	500,000,000	500,000,000
Common Stock, Shares, Issued	75,879,025	77,470,886	100,596,918	102,202,753
Common Stock, Shares, Outstanding	74,145,251	75,737,112	98,863,144	100,468,979
Preferred Stock, Shares Authorized	10,000,000	10,000,000	10,000,000	10,000,000
Preferred Stock, Shares Issued	165,045	165,045	193,507	193,507
Treasury Stock, Common, Shares	1,733,774	1,733,774	1,733,774	1,733,774

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$-83,068	$-64,663	$-60,606	$-36,293
Net Cash Provided by (Used in) Operating Activities	$-36,315	$-26,538	$-24,587	$328
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect	$19,478	$16,181	$-16,104	$10,802
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$33,488	$49,669	$33,565	$24,106
Depreciation, Depletion and Amortization	$5,873	$6,287	$6,944	$6,809
Payments to Acquire Property, Plant, and Equipment	$4,567	$3,789	$3,200	$3,614
Amortization of Debt Issuance Costs	$6,205	$6,305	$8,380	$4,844
Proceeds from Sale of Productive Assets	—	—	$126	$0
Proceeds from Sale and Maturity of Marketable Securities	$81,258	$50,000	$0	$0
Share-based Payment Arrangement, Noncash Expense	$17,810	$11,152	$4,551	$5,097
Net Cash Provided by (Used in) Investing Activities	$62,640	$46,211	$-3,074	$-3,614
Fair Value Adjustment of Warrants	$286	$-619	$247	$-23
Derivative, Gain (Loss) on Derivative, Net	$878	$2,697	$-12,206	$-3,157
Unrealized Gain (Loss) on Investments	$249	$133	$0	$0
Accretion (Amortization) of Discounts and Premiums, Investments	$2,631	$500	$0	$0
Deferred Income Tax Expense (Benefit)	$-76	$0	$-32	$0
Gain (Loss) on Disposition of Property Plant Equipment	$30	$-271	$0	$-28
Proceeds from Issuance of Private Placement	—	—	$15,359	$0
Proceeds from Issuance of Common Stock	—	$75	$13,841	$13,841
Payment for Contingent Consideration Liability, Financing Activities	$2,584	$2,372	$50	$50
Repayments of Long-term Debt	—	—	$20,000	$0
Finance Lease, Principal Payments	$101	$39	$37	$34
Proceeds from Warrant Exercises	—	—	$517	$517
Proceeds from Stock Options Exercised	$126	—	$2,767	$538
Net Cash Provided by (Used in) Financing Activities	$-6,847	$-3,492	$11,557	$14,088
Convertible Preferred Stock Converted to Other Securities	—	—	$4,111	$0
Increase (Decrease) in Accounts Receivable	$4,564	$5,975	$12,308	$10,690
Increase (Decrease) in Inventories	$4,385	$-3,639	$6,836	$4,225
Increase (Decrease) in Other Receivables	$-66	$-205	$274	$84
Increase (Decrease) in Prepaid Expense	$-3,128	$-1,176	$-2,033	$-2,594
Increase (Decrease) in Other Noncurrent Assets	$84	$28	$17	$71
Increase (Decrease) in Accrued Liabilities	$3,357	$9,471	$-448	$4,643
Increase (Decrease) in Accounts Payable	$5,057	$9,215	$19,638	$25,260
IncreaseDecreaseInOperatingLeaseLiability	$-5,324	$-2,828	$-452	$-824
Increase (Decrease) in Other Noncurrent Liabilities	$-443	$-203	$-11	$106
Interest Paid, Excluding Capitalized Interest, Operating Activities	$4,506	$4,498	$3,914	$3,512

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("DFPH","financials")

Full statements spill as a table. For one cell: =jivedata("DFPH","Revenue") or =jivedata("DFPH","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.